We also evaluated the expression of other PPAR-α-related genes in both UC and CD patients, including PPARGC1B, ACOX (39) and HMGCS2 (40), all of which were downregulated, indicating that PPAR-α pathway is impaired in IBD, and confirmed by pathway enrichment analysis. This evidence concerns the gene HMGCS2 and inflammatory bowel disease.